The epithelial/fibroblastic pathway in the pathogenesis of idiopathic pulmonary fibrosis: Tying loose ends

American Journal of Respiratory Cell and Molecular Biology

Volumn 29, Issue 3 II, 2003, Pages

  Selman, Moisés ^a   Pardo, Annie ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERSTITIAL COLLAGENASE; MATRILYSIN;

APOPTOSIS; CONFERENCE PAPER; EFFECTOR CELL; FIBROBLAST; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROSIS; PATHOGENESIS; PATHOPHYSIOLOGY; TISSUE REPAIR;

EID: 0041827226     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (61)

1. Selman, M., T. E. King, and A. Pardo. 2001. Idiopathic pulmonary fibrosis: prevaling and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Intern. Med. 134:136-151.
2. Pardo, A., and M. Selman. 2002. Molecular mechanisms of pulmonary fibrosis. Front. Biosci. 7:d1743-d1761.
3. Katzenstein, A. L., D. A. Zisman, L. A. Litzky, B. T. Nguyen, and R. M. Kotloff. 2002. Usual interstitial pneumonia: histologic study of biopsy and explant specimens. Am. J. Surg. Pathol. 26:1567-1577.
4. Non-neoplastic disorders of the lower respiratory tract. Travis, D. W. D., T. V. Colby, M. N. Koss, M. L. Rosado de Chritenson, N. L. Muller, and T. E. King editors. The American Registry of Pathology; Atlas of Non-tumor Pathology, First Series, Fascicle 2, 2002.
5. Scott, J., I. Johnston, and J. Britton. 1990. What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. BMJ 301:1015-1017.
6. Iwai, K., T. Mori, N. Yamada, M. Yamaguchi, and Y. Hosoda. 1994. Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure. Am. J. Respir. Crit. Care Med. 150:670-675.
7. Hubbard, R., S. Lewis, K. Richards, I. Johnston, and J. Britton. 1996. Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet 347:284-289.
8. Tobin, R. W., C. E. Pope, C. A. Pellegrini, M. J. Emond, J. Sillery, and G. Raghu. 1998. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 158:1804-1808.
9. Egan, J. J., A. A. Woodcock, and J. P. Stewart. 1997. Viruses and idiopathic pulmonary fibrosis. Eur. Respir. J. 10:1433-1437.
10. Egan, J. J., J. P. Stewart, P. S. Hasleton, J. R. Arrand, K. B. Carroll, and A. A. Woodcock. 1995. Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. Thorax 50:1234-1239.
11. Kelly, B. G., S. S. Lok, P. S. Hasleton, J. J. Egan, and J. P. Stewart. 2002. A rearranged form of Epstein-Barr virus DNA is associated with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 166:510-513.
12. Qunn, L., T. Takemura, S. Ikushima, T. Ando, T. Yanagawa, O. Akiyama, M. Oritsu, N. Tanaka, and T. Kuroki. 2002. Hyperplastic epithelial foci in honeycomb lesions in idiopathic pulmonary fibrosis. Virchows Arch. 441:271-278.
13. Honda, T., H. Ota, K. Arai, M. Hayama, K. Fujimoto, Y. Yamazaki, and M. Anuda. 2002. Three-dimensional analysis of alveolar structure in usual interstitial pneumonia. Virchows Arch. 441:47-52.
14. Kuwano, K., R. Kunitake, M. Kawasaki, Y. Nomoto, N. Hagimoto, Y. Nakanishi, and N. Hara. 1996. P21Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 154:477-483.
15. Uhal, B. D., I. Joshi, C. W. F. Hughes, C. Ramos, A. Pardo, and M. Selman. 1998. Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am. J. Physiol. 275:L1192-L1199.
16. Barbas-Filho, J. V., M. A. Ferreira, A. Sesso, R. A. Kairalla, C. R. Carvalho, and V. L. Capelozzi. 2001. Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP). J. Clin. Pathol. 54:132-138.
17. Maeyama, T., K. Kuwano, M. Kawasaki, R. Kunitake, N. Hagimoto, T. Matsuba, M. Yoshimi, I. Inoshima, K. Yoshida, and N. Hara. 2001. Upregulation of Fas-signalling molecules in lung epithelial cells from patients with idiopathic pulmonary fibrosis. Eur. Respir. J. 17:180-189.
18. Wang, R., C. Ramos, I. Joshi, A. Zagariya, A. Pardo, M. Selman, and B. D. Uhal. 1999. Human lung myofibroblast-derived inducers of alveolar epithelial apoptosis identified as angiotensin peptides. Am. J. Physiol. 277:L1158-L1164.
19. Chilosi, M., V. Poletti, B. Murer, M. Lestani, A. Cancellieri, L. Montagna, P. Piccoli, G. Cangi, G. Semenzato, and C. Doglioni. 2002. Abnormal re-epithelialization and lung remodeling in idiopathic pulmonary fibrosis: the role of deltaN-p63. Lab. Invest. 82:1335-1345.
20. Sheppard, D. 2001. Pulmonary fibrosis: a cellular overreaction or a failure of communication? J. Clin. Invest. 107:1501-1502.
21. Adamson, I. Y. R, L. Young, and D. H. Bowden. 1988. Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am. J. Pathol. 130:377-383.
22. Dai, J., B. Gilks, K. Price, and A. Churg. 1998. Mineral dusts directly induce epithelial and interstitial fibrogenic mediators and matrix components in the airway wall. Am. J. Respir. Crit. Care Med. 158:1907-1913.
23. Morishima, Y., A. Nomura, Y. Uchida, Y. Noguchi, T. Sakamoto, Y. Ishii, Y. Goto, K. Masuyama, M. J. Zhang, K. Hirano, M. Mochizuki, M. Ohtsuka, and K. Sekizawa. 2001. Triggering the induction of myofibroblast and fibrogenesis by airway epithelial shedding. Am. J. Respir. Cell Mol. Biol. 24:1-11.
24. Antoniades, H. N., M. A. Bravo, R. E. Avila, T. Galanopoulus, J. Neville, and M. Selman. 1990. Plalelet-derived growth factor in idiopathic pulmonary fibrosis. J. Clin. Invest. 86:1055-1064.
25. Kapanci, Y., A. Desmouliere, J. C. Pache, M. Redard, and G. Gabbiani. 1995. Cytoskeletal protein modulation in pulmonary alveolar myofibroblasts during idiopathic pulmonary fibrosis: possible role of transforming growth factor β and tumor necrosis factor α. Am. J. Respir. Crit. Care Med. 152:2163-2169.
26. Nash, J. R., P. J. McLaughlin, D. Butcher, and B. Corrin. 1993. Expression of tumour necrosis factor-alpha in cryptogenic fibrosing alveolitis. Histopathology 22:343-347.
27. Khalil, N., R. N. O'Connor, H. W. Unruh, P. W. Warren, K. C. Flanders, A. Kemp, O. H. Bereznay, and A. H. Greenberg. 1991. Increased production and immunohistochemical localization of transforming growth factor-β in idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 5:155-162.
28. Khalil, N., R. N. O'Connor, K. C. Flanders, and H. Unruh. 1996. TGF-β1, but not TGF-β2 or TGF-β3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. Am. J. Respir. Cell Mol. Biol. 14:131-138.
29. Giaid, A., R. P. Michel, D. J. Stewart, M. Sheppard, B. Corrin, and Q. Hamid. 1993. Expression of endothelin-1 in lung of patients with cryptogenic fibrosing alveolitis. Lancet 341:1550-1554.
30. Pan, L. H., K. Yamauchi, M. Uzuki, T. Nakanishi, M. Takigawa, H. Inoue, and T. Sawai. 2001. Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF. Eur. Respir. J. 17:1220-1227.
31. Young, L., and I. Y. R. Adamson. 1993. Epithelial-fibroblast interactions in bleomycin-induced lung injury and repair. Environ. Health Perspect. 101:56-61.
32. Kotani, I., A. Sato, H. Hayakawa, T. Urano, Y. Takada, and A. Takada. 1995. Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis. Thromb. Res. 77:493-504.
33. Imokawa, S., A. Sato, H. Hayakawa, M. Kotani, T. Urano, and A. Takada. 1997. Tissue factor expression and fibrin deposition in the lungs of patients with idiopathic pulmonary fibrosis and systemic sclerosis. Am. J. Respir. Crit. Care Med. 156:631-636.
34. Fujii, M., H. Hayakawa, T. Urano, A. Sato, K. Chida. H. Nakamura, and A. Takada. 2000. Relevance of tissue factor and tissue factor pathway inhibitor for hypercoagulable state in the lungs of patients with idiopathic pulmonary fibrosis. Thromb. Res. 99:111-117.
35. Murphy, G., H. Stanton, S. Cowell, G. Butler, V. Knauper, S. Atkinson, and J. Gavrilovic. 1999. Mechanisms for pro matrix metalloproteinase activation. APMIS 107:38-44.
36. Legrand, C., M. Polette, J. M. Tournier, S. De Bentzmann, E. Huet, C. Monteau, and P. Birembaut. 2001. uPa/plasmin system-mediated MMP-9 activation is implicated in bronchial epithelial cell migration. Exp. Cell Res. 264:326-336.
37. Howell, D. C., G. J. Laurent, and R. C. Chambers. 2002. Role of thrombin and its major cellular receptor, protease-activated receptor-1, in pulmonary fibrosis. Biochem. Soc. Trans. 30:211-216.
38. Bogatkevich, G. S., E. Tourkina, R. M. Silver, and A. Ludwicka-Bradley. 2001. Thrombin differentiates normal lung fibroblasts to a myofibroblast phenotype via the proteolytically activated receptor-1 and a protein kinase C-dependent pathway. J. Biol. Chem. 276:45184-45192.
39. Zuo, F., N. Kaminski, E. Eugui, J. Allard, Z. Yakhini, A. Ben-Dor, L. Lollini, D. Morris, Y. Kim, B. DeLustro, D. Sheppard, A. Pardo, M. Selman, and R. A. Heller. 2002. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc. Natl. Acad. Sci. USA 99:6292-6297.
40. Selman, M., V. Ruiz, S. Cabrera, L. Segura, R. Ramírez, R. Barrios, and A. Pardo. 2000. TIMP-1, -2, -3 and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? Am. J. Physiol. 279:L562-L574.
41. Winkler, M. K., and J. L. Fowlkes. 2002. Metalloproteinase and growth factor interactions: do they play a role in pulmonary fibrosis? Am. J. Physiol. 283:L1-11.
42. Cameron, J. S. 1996. The enigma of focal segmental glomerulosclerosis. Kidney Int. S119-S131.
43. Schwartz, M. M., J. Evans, R. Bain, and S. M. Korbet. 1999. Focal segmental glomerulosclerosis: prognostic implications of the cellular lesion. J. Am. Soc. Nephrol. 10:1900-1907.
44. Korbet, S. M., M. M. Schwartz, and E. J. Lewis. 1988. Recurrent nephrotic syndrome in renal allografts. Am. J. Kidney Dis. 11:270-276.
45. Kinnman, N., and C. Housset. 2002. Peribiliary myofibroblasts in biliary type liver fibrosis. Front. Biosci. 7:d496-d503.
46. Lindblad, A., R. Hultcrantz, and B. Strandvik. 1992. Bile-duct destruction and collagen deposition: a prominent ultrastructural feature of the liver in cystic fibrosis. Hepatology 16:372-381.
47. Kinnman, N., A. Lindblad, C. Housset, E. Buentke, A. Scheynius, B. Strandvik, and R. Hultcrantz. 2000. Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis. Hepatology 32:334-340.
48. Chamberlain, C. G., and J. W. McAvoy. 1997. Fiber differentiation and polarity in the mammalian lens: a key role for FGF. Prog. Retin. Eye Res. 16:443-478.
49. Green, W. R., and P. J. McDonnell. 1985. Opacification of the posterior capsule. Trans. Ophthalmol. Soc. U. K. 104:727-739.
50. Hatae, T., T. Ishibashi, F. Yoshitomi, and Y. Shibata. 1993. Immunocytochemistry of types I-IV collagen in human anterior subcapsular cataracts. Graefes Arch. Clin. Exp. Ophthalmol. 231:586-590.
51. Novotny, G. E., H. Pau, and G. Arnold. 1989. Organization of collagen and other extracellular material in anterior capsular cataract. Anat. Anz. 168:127-133.
52. Srinivasan, Y., F. J. Lovicu, and P. A. Overbeek. 1998. Lens-specific expression of transforming growth factor 1 in transgenic mice causes anterior subcapsular cataracts. J. Clin. Invest. 101:625-634.
53. Lee, E. H., Y. Seomun, K. H. Hwang, J. E. Kim, I. S. Kim, J. H. Kim, and C. K. Joo. 2000. Overexpression of the transforming growth factor-β -inducible gene βig-h3 in anterior polar cataracts. Invest. Ophthalmol. Vis. Sci. 41:1840-1845.
54. Lovicu, F. J., M. W. Schulz, A. M. Hales, L. N. Vincent, P. A. Overbeek, C. G. Chamberlain, and J. W. McAvoy. 2002. TGFbeta induces morphological and molecular changes similar to human anterior subcapsular cataract. Br. J. Ophthalmol. 86:220-226.
55. King, T. E., Jr., M. I. Schwarz, K. Brown, J. A. Tooze, T. V. Colby, J. A. Waldron, A. Flint, W. Thurlbeck, and R. M. Cherniack. 2001. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am. J. Respir. Crit. Care Med. 164:1025-1032.
56. Nicholson, A. G., L. G. Fulford, T. V. Colby, R. M. du Bois, D. M. Hansell, and A. U. Wells. 2002. The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 166:173-177.
57. Nozaki, Y., T. Liu, K. Hatano, M. Gharaee-Kermani, and S. H. Phan. 2000. Induction of telomerase activity in fibroblasts from bleomycin-injured lungs. Am. J. Respir. Cell Mol. Biol. 23:460-465.
58. Zhang, K., M. D. Rekhter, D. Gordon, and S. H. Phan. 1994. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis: a combined immunohistochemical and in situ hybridization study. Am. J. Pathol. 145:114-125.
59. Zeisberg, M., G. Bonner, Y. Maeshima, P. Colorado, G. A. Müller, F. Strutz, and R. Kalluri. 2001. Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation. Am. J. Pathol. 159:1313-1321.
60. Ng, Y, Y., T. P. Huang, W. C. Yang, Z. P. Chen, A. H. Yang, W. Mu, D. J. Nikolic-Paterson, R. C. Atkins, and H. Y. Lan. 1998. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int. 54:864-876.
61. Iwano, M., D. Plieth, T. M. Danoff, C. Xue, H. Okada, and E. G. Neilson. 2002. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 110:341-350.